About Relay Therapeutics
Relay Therapeutics is a company based in Cambridge (United States) founded in 2016 by Dorothee Kern and David E Shaw.. Relay Therapeutics has raised $520 million across 4 funding rounds from investors including ARE, SoftBank Vision Fund and Perceptive Advisors. The company has 261 employees as of December 31, 2024. Relay Therapeutics has completed 1 acquisition, including ZebiAI. Relay Therapeutics offers products and services including Dynamo Platform and Therapeutic Pipeline. Relay Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Cambridge, United States
- Employees 261 as on 31 Dec, 2024
- Founders Dorothee Kern, David E Shaw
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Relay Therapeutics, Inc.
-
Annual Revenue
$10.01 M-60.83as on Dec 31, 2024
-
Net Profit
$-337.71 M1.25as on Dec 31, 2024
-
EBITDA
$-380.21 M-1.62as on Dec 31, 2024
-
Total Equity Funding
$520 M (USD)
in 4 rounds
-
Latest Funding Round
$30 M (USD), Post-IPO
Jan 10, 2024
-
Investors
ARE
& 12 more
-
Employee Count
261
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Relay Therapeutics
Relay Therapeutics is a publicly listed company on the NASDAQ with ticker symbol RLAY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Relay Therapeutics
Relay Therapeutics offers a comprehensive portfolio of products and services, including Dynamo Platform and Therapeutic Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables visualization of protein motion for developing new therapeutics.
Advances candidates for oncology and genetic disease treatments.
Unlock access to complete
Leadership Team
21 people
Finance and Accounting
11 people
Product Management Team
10 people
Operations Team
6 people
Senior Team
4 people
Legal and Compliance
3 people
Software Development Team
2 people
Data Analysis and Operations Team
2 people
Unlock access to complete
Funding Insights of Relay Therapeutics
Relay Therapeutics has successfully raised a total of $520M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $30 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $30.0M
-
First Round
First Round
(14 Sep 2016)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Post-IPO - Relay Therapeutics | Valuation |
investors |
|
| Dec, 2018 | Amount | Series C - Relay Therapeutics | Valuation | SoftBank Vision Fund | |
| Dec, 2017 | Amount | Series B - Relay Therapeutics | Valuation | BVF Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Relay Therapeutics
Relay Therapeutics has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, SoftBank Vision Fund and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Relay Therapeutics
Relay Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ZebiAI. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI solutions for small molecule drug discovery are provided.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Relay Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Relay Therapeutics Comparisons
Competitors of Relay Therapeutics
Relay Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Relay Therapeutics
Frequently Asked Questions about Relay Therapeutics
When was Relay Therapeutics founded?
Relay Therapeutics was founded in 2016.
Where is Relay Therapeutics located?
Relay Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Relay Therapeutics?
Sanjiv Patel is the current CEO of Relay Therapeutics.
Is Relay Therapeutics a funded company?
Relay Therapeutics is a funded company, having raised a total of $520M across 4 funding rounds to date. The company's 1st funding round was a Series B of $63M, raised on Sep 14, 2016.
How many employees does Relay Therapeutics have?
As of Dec 31, 2024, the latest employee count at Relay Therapeutics is 261.
What is the annual revenue of Relay Therapeutics?
Annual revenue of Relay Therapeutics is $10.01M as on Dec 31, 2024.
What does Relay Therapeutics do?
Relay Therapeutics was founded in 2016 and is based in Cambridge, United States. Operations center on a drug discovery engine that generates 3D visualizations of protein mobility to analyze protein functions through motion. Ligand-binding pockets in proteins are examined, and interactions between ligands and proteins are identified. Initial efforts are directed toward oncology therapeutics.
Who are the top competitors of Relay Therapeutics?
Relay Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Relay Therapeutics offer?
Relay Therapeutics offers Dynamo Platform and Therapeutic Pipeline.
Is Relay Therapeutics publicly traded?
Yes, Relay Therapeutics is publicly traded on NASDAQ under the ticker symbol RLAY.
How many acquisitions has Relay Therapeutics made?
Relay Therapeutics has made 1 acquisition, including ZebiAI.
Who are Relay Therapeutics's investors?
Relay Therapeutics has 13 investors. Key investors include ARE, SoftBank Vision Fund, Perceptive Advisors, Google Ventures, and Casdin Capital.
What is Relay Therapeutics's ticker symbol?
The ticker symbol of Relay Therapeutics is RLAY on NASDAQ.